These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8330463)

  • 1. Multiple-dose phase I study of transnasal butorphanol.
    Shyu WC; Pittman KA; Robinson D; Barbhaiya RH
    Clin Pharmacol Ther; 1993 Jul; 54(1):34-41. PubMed ID: 8330463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.
    Davis GA; Rudy AC; Archer SM; Wermeling DP
    Am J Health Syst Pharm; 2004 Feb; 61(3):261-6. PubMed ID: 14986556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
    Vachharajani NN; Shyu WC; Garnett WR; Morgenthien EA; Barbhaiya RH
    Clin Pharmacol Ther; 1996 Sep; 60(3):283-94. PubMed ID: 8841151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.
    Shyu WC; Pittman KA; Robinson DS; Barbhaiya RH
    Eur J Clin Pharmacol; 1993; 45(6):559-62. PubMed ID: 8157043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of butorphanol and its metabolites at steady state following nasal administration in humans.
    Vachharajani NN; Shyu WC; Greene DS; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Apr; 18(3):191-202. PubMed ID: 9113342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol.
    Shyu WC; Morgenthien EA; Pittman KA; Barbhaiya RH
    Eur J Clin Pharmacol; 1994; 47(1):57-60. PubMed ID: 7988625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of butorphanol nasal spray in patients with renal impairment.
    Shyu WC; Morgenthien EA; Barbhaiya RH
    Br J Clin Pharmacol; 1996 May; 41(5):397-402. PubMed ID: 8735680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanol.
    Shyu WC; Mayol RF; Pfeffer M; Pittman KA; Gammans RE; Barbhaiya RH
    Biopharm Drug Dispos; 1993 Jul; 14(5):371-9. PubMed ID: 8218955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate.
    Srinivas NR; Shyu WC; Upmalis D; Lee JS; Barbhaiya RH
    J Clin Pharmacol; 1995 Apr; 35(4):432-7. PubMed ID: 7650235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of transnasal butorphanol tartrate in postepisiotomy pain: a model to assess analgesia.
    Joyce TH; Kubicek MF; Skjonsby BS; Jones MM
    Clin Ther; 1993; 15(1):160-7. PubMed ID: 8458045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of intranasal butorphanol administered from a single-dose sprayer.
    Davis GA; Rudy AIa; Archer SM; Wermeling DP
    Am J Health Syst Pharm; 2005 Jan; 62(1):48-53. PubMed ID: 15658072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of butorphanol after intravenous, intramuscular, and oral administration in Hispaniolan Amazon parrots (Amazona ventralis).
    Guzman DS; Flammer K; Paul-Murphy JR; Barker SA; Tully TN
    J Avian Med Surg; 2011 Sep; 25(3):185-91. PubMed ID: 22216718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of butorphanol tartrate in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus).
    Riggs SM; Hawkins MG; Craigmill AL; Kass PH; Stanley SD; Taylor IT
    Am J Vet Res; 2008 May; 69(5):596-603. PubMed ID: 18447789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration.
    Vachharajani NN; Shyu WC; Nichola PS; Boulton DW
    Cephalalgia; 2002 May; 22(4):282-7. PubMed ID: 12100090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of pharmacokinetic interaction between butorphanol nasal spray and cimetidine.
    Shyu WC; Barbhaiya RH
    Br J Clin Pharmacol; 1996 Oct; 42(4):513-7. PubMed ID: 8904627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction between butorphanol nasal spray and oral metoclopramide in healthy women.
    Vachharajani NN; Shyu WC; Barbhaiya RH
    J Clin Pharmacol; 1997 Oct; 37(10):979-85. PubMed ID: 9505990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age on the pharmacokinetics of butorphanol.
    Ramsey R; Higbee M; Maesner J; Wood J
    Acute Care; 1988; 12 Suppl 1():8-16. PubMed ID: 3344601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.